Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-001728
Filing Date
2018-01-18
Accepted
2018-01-18 09:07:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 114832
  Complete submission text file 0000000000-18-001728.txt   160483
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Aviragen Therapeutics, Inc. (Filed for) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filed for) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)